EUVIMEDEUVIMED entdecken
Crossref

Neuropilin‐1 enhances temozolomide resistance in glioblastoma via the STAT1/p53/p21 axis

Ping Huang iD, Lixia Zhang, Hongwei Wang iD, Changwu Dou, Haitao Ju, Peng Yue, Jiaxing Ren

Neuropathology · 2024

DOI: 10.1111/neup.12966 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropathology, 2024. Verfasst von Ping Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China. Hauptthemen laut MEDLINE: Temozolomide, Glioblastoma, Drug Resistance, Neoplasm, Neuropilin-1. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Inner Mongolia Medical University Affiliated Hospital, Inner Mongolia Autonomous Region Clinical Medicine Research Center of Nervous System Diseases, Hohhot Religion High-quality Developmental and Advantageous Key Clinical Project of Neurological System Disease.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is the most prevalent primary intracranial tumor. Temozolomide (TMZ) is the first‐line chemotherapy for GBM. Nonetheless, the development of TMZ resistance has become a main cause of treatment failure in GBM patients. Evidence suggests that neuropilin‐1 (NRP‐1) silencing can attenuate GBM cell resistance to TMZ. This study aims to determine potential mechanisms by which NRP‐1 affects TMZ resistance in GBM. The parental U251 and LN229 GBM cells were exposed to increasing concentrations of TMZ to construct TMZ‐resistant GBM cells (U251/TMZ, LN229/TMZ). BALB/c nude mice were injected with U251/TMZ cells to establish the xenograft mouse model. Functional experiments were carried out to examine NRP‐1 functions. Western blotting and real‐time quantitative polymerase chain reaction were used to evaluate molecular protein and mRNA expression, respectively. Immunohistochemical staining showed NRP‐1 and STAT1 expression in mouse tumors. The results showed that NRP‐1 was highly expressed in TMZ‐resistant cells. Moreover, knocking down NRP‐1 attenuated the TMZ resistance of U251/TMZ cells, while upregulating NRP‐1 enhanced TMZ resistance of the parental cells. NRP‐1 silencing elevated GBM cell sensitivity to TMZ in tumor‐bearing mice. Depleting NRP‐1 reduced STAT1, p53, and p21 expression in U251/TMZ cells. STAT1 depletion offset NRP‐1 silencing evoked attenuation of GBM cell resistance to TMZ. Collectively, our study reveals that NRP‐1 enhances TMZ resistance in GBM possibly by regulating the STAT1/p53/p21 axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TemozolomideGlioblastomaDrug Resistance, NeoplasmNeuropilin-1STAT1 Transcription FactorAntineoplastic Agents, AlkylatingMice, NudeTumor Suppressor Protein p53Brain NeoplasmsMice, Inbred BALB CAnimalsHumansCell Line, TumorMiceCyclin-Dependent Kinase Inhibitor p21Signal TransductionXenograft Model Antitumor Assays

Stichwörter der Autor:innen

STAT1/p53/p21drug resistanceglioblastoma (GBM)neuropilin‐1(NRP‐1)temozolomide (TMZ)

Substanzen

TemozolomideNeuropilin-1STAT1 Transcription FactorAntineoplastic Agents, AlkylatingTumor Suppressor Protein p53STAT1 protein, humanCyclin-Dependent Kinase Inhibitor p21NRP1 protein, humanTP53 protein, humanCDKN1A protein, human

Autor:innen und Institutionen

  • Department of Neurosurgery, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
  • Inner Mongolia Clinical Medical Research Center of Nervous System Diseases, Hohhot, China.
  • Hohhot Mongolian Medicine of Traditional Chinese Medicine Hospital, Hohhot, China.
  • Inner Mongolia Medical University, Hohhot, China.

ORCID-Profile: Ping Huang, Hongwei Wang

Förderung

  • Inner Mongolia Medical University Affiliated Hospital
  • Inner Mongolia Autonomous Region Clinical Medicine Research Center of Nervous System Diseases
  • Hohhot Religion High-quality Developmental and Advantageous Key Clinical Project of Neurological System Disease
  • National Natural Science Foundation of China
  • Natural Science Foundation of Inner Mongolia Autonomous Region
  • Science Research Project of Colleges and Universities in Inner Mongolia Autonomous Region
  • Inner Mongolia Medical University Joint Project

Zitieren

APA

Huang, P., Zhang, L., Wang, H., Dou, C., Ju, H., Yue, P., & Ren, J. (2024). Neuropilin‐1 enhances temozolomide resistance in glioblastoma via the STAT1/p53/p21 axis. Neuropathology. https://doi.org/10.1111/neup.12966

Vancouver

Huang P, Zhang L, Wang H, Dou C, Ju H, Yue P, et al. Neuropilin‐1 enhances temozolomide resistance in glioblastoma via the STAT1/p53/p21 axis. Neuropathology. 2024. doi:10.1111/neup.12966

BibTeX
@article{Huang2024,
  author = {Huang, Ping and Zhang, Lixia and Wang, Hongwei and Dou, Changwu and Ju, Haitao and Yue, Peng and Ren, Jiaxing},
  title = {Neuropilin‐1 enhances temozolomide resistance in glioblastoma via the STAT1/p53/p21 axis},
  journal = {Neuropathology},
  year = {2024},
  doi = {10.1111/neup.12966}
}
Kostenlos starten →